Miriplatin hydrate Supplier & Distributor of CAS# 141977-79-9

Miriplatin hydrate

Quantity:

add to inquiry

Product Description:

Miriplatin hydrate is a platinum-based antineoplastic agent used in cancer treatment, particularly for hepatocellular carcinoma.

Applications & Uses:

CAS#:

141977-79-9

SYNONYM:

Dihydrogen (OC-6-43)-[[bis(1-oxoallyl)-KappaO]amino]hexanoato(2-)-O6,N,N']platinum;Miriplatin;SM-11355

FORMULA:

C14H22N2O4Pt

PRODUCT TYPE:

HAZARD:

Harmful

CATEGORIES:

Pharmaceutical

Technical Specifications

Appearance :

White crystalline powder

Molecular weight, g/mol :

650.28

Miriplatin hydrate is a potent platinum-based antineoplastic agent specifically designed to enhance the efficacy of cancer treatment. Its unique chemical composition enables it to effectively bind to DNA, disrupting the replication process and ultimately leading to cell death. This targeted mechanism makes Miriplatin hydrate an invaluable asset in the therapeutic arsenal against various types of malignancies, particularly hepatocellular carcinoma. In clinical settings, it is often employed as a key component in transarterial chemoembolization (TACE) procedures, delivering localized chemotherapy directly to tumor sites, thus minimizing systemic exposure and reducing potential side effects. With its innovative formulation, Miriplatin hydrate presents a significant advancement in cancer treatment, offering healthcare professionals an effective tool in their quest to combat cancerous growths and improve patient outcomes.

Details

CAS #

141977-79-9

CATEGORIES:

Pharmaceutical

Having Trouble Finding A Specific Product?
We Will Find It For You!

GET A QUICK QUOTE NOW

Recent Searches

Trending Now

Markets

Process Point

Process Point, LLC.

500 Office Center Drive, Suite 803
Fort Washington, PA 19034
Phone: 855-453-6208

Email: hello@processpointchem.com

Your Product Inquiry

You have not added any products to your inquiry.

Click Here to search our product database.

Unsent Inquiries: